Deverick Anderson to Drug Resistance, Multiple, Bacterial
This is a "connection" page, showing publications Deverick Anderson has written about Drug Resistance, Multiple, Bacterial.
Connection Strength
1.143
-
Effectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with multidrug-resistant organisms and Clostridium difficile: a secondary analysis of a multicentre cluster randomised controlled trial with crossover design (BETR Disinfection). Lancet Infect Dis. 2018 08; 18(8):845-853.
Score: 0.401
-
Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-H30Rx and ST131-H30R1 Strains. Antimicrob Agents Chemother. 2017 08; 61(8).
Score: 0.378
-
Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study. Lancet. 2017 02 25; 389(10071):805-814.
Score: 0.364